‘Indigenous lockdown protester vividly remembers the day she was taken to the ground by a group of Victorian Police officers at a demonstration in September last year.
Ocearna says it will be hard to forgive Victoria Police for the brutal takedown.’https://rumble.com/v1iuob7-police-pursue-victim-of-violent-lockdown-arrest.html?mref=6zof&mrefc=2
Covid is going to get worse according to the Australian Federal Government BUT at the same time they (the government) will stop free RAT tests, scale back pandemic leave and telehealth consultations! Yep, they believe Covid is serious BUT……
‘We know that SARS-CoV-2 is a man-made “paravirus” if you will, created in Wuhan/Moderna laboratories and reinforced by mainstream media propaganda. But in the grand scheme, at least the first iteration released onto the world, so-called COVID-19 is a lightweight illness that is mostly just rebranded influenza.
The mRNA and viral vector injections, along with Remdesivir, combine for a quick two-year, $200 billion global racket for big pharma and Bill Gates. Ivermectin is a proven, powerful drug to treat and prevent so-called COVID-19, according to 108 peer-reviewed studies. The Ivermectin Merck patents are long expired. So the cheap, $1-per-dose, Nobel Prize-winning drug poses a serious threat not only to the emergency use authorizations for the lethal injections, but also to the temporary COVID-19 racket. But those simply cannot be the only reasons for the persistent, petulant, childish mainstream media anti-Ivermectin propaganda.
The cancer industry will surpass $522 billion per year by 2028, according to Global Market Insights. Market analytics firm Precedent Research predicts the cancer industrial complex will surpass $581 billion annually by 2030. The COVID Blog™ has chronicled the strong correlation (perhaps causal relationship) between mRNA injections and cancer. Cancer has been a goldmine for big pharma since the 1960s. The average cancer patient is worth about $160,000 to the cancer industrial complex. Big pharma will never offer a cure, nor will the industry allow off-label, cheap, effective cancer treatments.
This blogger has seen scattered studies concluding that Ivermectin not only inhibits cancer cell growth, but also kills cancer cells. Perhaps placing nine said studies into one article can help disrupt the cancer industrial complex and wake up the snoozing masses.
This study by researchers at Unidad de Investigación Biomédica en Cáncer in Mexico concluded:
So far, at least 235 clinically-approved, non-cancer drugs have proven anti-tumor activity either in vitro, in vivo, or even clinically. Among these, ivermectin, an anti-parasitic compound of wide use in veterinary and human medicine, is clearly a strong candidate for repositioning, based on the fact that:
i) it is very safe, causing almost no side-effects other than those caused by the immune and inflammatory responses against the parasite in infected patients, and
ii) it has proven anti-tumor activity in pre-clinical studies. On the other hand, it is now evident that the use of very selective “unitargeted” drugs is commonly associated to early development of resistance by cancer cells, hence the use of “dirty” or “multitargeted” drugs is important to explore.
Some key findings by Chinese researchers at Bengbu Medical College include the following:
Researchers at Henan University in China concluded:
We have demonstrated that ivermectin may regulate the expression of crucial molecules Caspase-3, Bax, Bcl-2, PARP, and Cleaved-PARP in the apoptosis pathway by increasing ROS production and inhibiting the cell cycle in the S phase to inhibit colorectal cancer cells (Figure 11). Therefore, current results indicate that ivermectin might be a new potential anticancer drug for treating human colorectal cancer and other cancers.
Researchers at the National Cancer Institute in Mexico City concluded the following:
Results from the present study demonstrated that ivermectin preferentially targeted the stem cell population in MDA–MB–231 human breast cancer cells. Ivermectin has been demonstrated to be safe, following treatment of millions of patients with onchocerciasis and other parasitic diseases, which makes it a strong candidate for further studies investigating its potential use as a repurposed drug for cancer therapy.
Some key findings from researchers at The Second Clinical Medical College in China:
Researchers at three Chinese institutions concluded:
Those findings provided the potential targeted lncRNA-EIF4A3-mRNA pathways of ivermectin in ovarian cancer, and constructed the effective prognostic model, which benefits discovery of novel mechanism of ivermectin to suppress ovarian cancer cells, and the ivermectin-related molecule-panel changes benefit for its personalized drug therapy and prognostic assessment towards its predictive, preventive, and personalized medicine (PPPM) in ovarian cancers.
Chinese researchers at Henan University, concluded the following:
We demonstrated that ivermectin effectively inhibit the proliferation of esophageal squamous cell carcinoma (ESCC) cells by inducing mitochondrial dysfunction, suppressing NF-κB signaling and promoting apoptosis. Our results suggest that ivermectin may be a potential therapeutic target against ESCC.
Some key findings from researchers at Instituto Nacional de Cancerologia in Mexico City:
Ivermectin reduced both cell viability and colony formation capacity in the stem cell-enriched population as compared with the parental one. Finally, in tumor-bearing mice ivermectin successfully reduced both tumor size and weight. Our results on the anti-tumor effects of ivermectin support its clinical testing.
Some key findings by University of Geneva researchers are as follows:
Constitutive activation of canonical WNT-TCF signaling is implicated in multiple diseases, including intestine and lung cancers, but there are no WNT-TCF antagonists in clinical use. We report that Ivermectin inhibits the expression of WNT-TCF targets, mimicking dnTCF, and that its low concentration effects are rescued by direct activation by TCFVP16.
In vivo, Ivermectin selectively inhibits TCF-dependent, but not TCF-independent, xenograft growth without obvious side effects. Given that Ivermectin is a safe anti-parasitic agent used by 200 million people against river blindness, our results suggest its additional use as a therapeutic WNT-TCF pathway response blocker to treat WNT-TCF-dependent diseases including multiple cancers.
‘Thursday, February 10, 2022 at 1:30 PM in the Des Moines, Iowa Capitol Representative Jon Jacobsen held a subcommittee meeting to discuss The Medical Privacy & Freedom Act HSB 647 in which citizens provided testimonies with their stories of injury, discrimination, coercion, and job loss as a result of mandates. Speakers traveled from across the state and were set to speak in the capitol until midnight or later. 34th District Democratic Representative Bruce Hunter became very upset with the incontestable testimonies that did not fall in line with his agenda and stormed off. Representative Jacobsen claimed he would continue taking testimonies in the capitol until morning if necessary; however, his plan fell short as people in opposition to the bill were disturbed by the indisputable testimonies and forced everyone to leave around 8 PM. Determined to provide everyone with a voice, Jon Jacobsen continued to take recorded testimonies at a bar down the street up until around 11:30 PM. The recorded testimonies from the bar were entered into the Iowa Capitol archives by February 18, 2022.
Registered Nurse, Jennifer Scott, reflects on all the lost employees resulting in a shortage of medical professionals due to vaccine mandates. She also continues to mention that they are having to bring in out-of-state medical professionals as contractors sometimes at 3 times the cost who are not vaccinated anyways. This results in more taxpayer money leaving Iowa when the problem could have been easily averted, had mandates never been put in place.’https://rumble.com/vzmjlk-nurse-complains-about-staffing-shortages-due-to-vaccine-mandates.html?mref=6zof&mc=dgip3&ep=2
The following is also from the previous article by the same author.
Dr Mike Yeadon: experienced life sciences R&D professional
Professional profile:
-Chief Scientific Advisor to America’s Frontline Doctors & to the Truth For Health Foundation.
-former founder and CEO of Ziarco, a biotech acquired by Novartis (2017).
-former VP and worldwide head of allergy & respiratory research at Pfizer, UK (1995-2011)
-independent consultant to over 30 biotech companies, mostly US (2011-2021).
-double first class honours degree in biochemistry & toxicology
-PhD in respiratory pharmacology’https://www.reignitedemocracyaustralia.com.au/how-much-was-true/
‘Dr. Peter McCullough, C-19 global expert, cardiologist, intensivist, epidemiologist, & academic, currently practicing in Dallas, TX. Dr. McCullough reviews the latest research, observational findings, and answers vaccine-related questions with Jodi O’Malley, MSN, RN Project Veritas whistleblower, and April Snipes RNFA & Owner of The Surgery Studio.’https://rumble.com/vrj4gh-dr.-peter-mccullough-informed-consent-with-covid-jab-potential-side-effects.html?mref=6zof&mc=dgip3&utm_source=newsletter&utm_medium=email&utm_campaign=Red+Voice+Media&ep=2
‘In this 10-minute video, Dr. Sucharit Bhakdi discusses the fundamental reason for the current wave of “breakthrough infections:” the failure of the COVID vaccines had to be expected, because fundamental principles of immunology were ignored in their design.’https://rumble.com/vpwf6g-the-covid-vaccines-were-designed-to-fail.html?mref=6zof&mc=dgip3&utm_source=newsletter&utm_medium=email&utm_campaign=tonyheller&ep=2
 | Elise on NY Times Warns Companies From… |
 | Martin on School Boards, Hot Mics &… |
 | pacanter7 on Creation News and Views Januar… |
 | Scriptural Vision on Climate Change & Community… |
 | crisscross767 on Prophetic Signs in the He… |
whatyareckon 